Campbell, Nancy D. (Author)
The history of an unnatural disaster—drug overdose—and the emergence of naloxone as a social and technological solution. For years, drug overdose was unmentionable in polite society. OD was understood to be something that took place in dark alleys—an ugly death awaiting social deviants—neither scientifically nor clinically interesting. But over the last several years, overdose prevention has become the unlikely object of a social movement, powered by the miracle drug naloxone. In OD, Nancy Campbell charts the emergence of naloxone as a technological fix for overdose and describes the remaking of overdose into an experience recognized as common, predictable, patterned—and, above all, preventable. Naloxone, which made resuscitation, rescue, and “reversal” after an overdose possible, became a tool for shifting law, policy, clinical medicine, and science toward harm reduction. Liberated from emergency room protocols and distributed in take-home kits to non-medical professionals, it also became a tool of empowerment. After recounting the prehistory of naloxone—the early treatment of OD as a problem of poisoning, the development of nalorphine (naloxone's predecessor), the idea of “reanimatology”—Campbell describes how naloxone emerged as a tool of harm reduction. She reports on naloxone use in far-flung locations that include post-Thatcherite Britain, rural New Mexico, and cities and towns in Massachusetts. Drawing on interviews with approximately sixty advocates, drug users, former users, friends, families, witnesses, clinicians, and scientists—whom she calls the “protagonists” of her story—Campbell tells a story of saving lives amid the complex, difficult conditions of an unfolding unnatural disaster.
...MoreReview Ulrich Koch (2020) Review of "OD: Naloxone and the Politics of Overdose". Pharmacy in History (pp. 61-62).
Review Joseph Spillane (2022) Review of "OD: Naloxone and the Politics of Overdose". Canadian Journal of Health History/Revue canadienne d’histoire de la santé (pp. 196-198).
Article
Arthur Daemmrich;
(2019)
Welcoming (Newbie) Scholars to the Field
(/isis/citation/CBB904595256/)
Book
Bita Moghaddam;
(2021)
Ketamine
(/isis/citation/CBB929329054/)
Article
Mickey C. Smith;
(2019)
Louis K. Liggett, Rexall, and Beyond
(/isis/citation/CBB952707406/)
Article
Ulrich Koch;
(2023)
“Heroin Mothers,” “Methadone Babies,” and the Medical Controversy over Methadone Maintenance in the Early 1970s
(/isis/citation/CBB373395945/)
Thesis
Hanganu-Bresch, Cristina;
(2008)
Faces of Depression: A Study of Antidepressant Advertisements in the American and British Journals of Psychiatry, 1960--2004
(/isis/citation/CBB001561430/)
Article
Mold, Alex;
(2004)
The “British System” of Heroin Addiction Treatment and the Opening of Drug Dependence Units, 1965--1970
(/isis/citation/CBB000770532/)
Book
Horace A. Bartilow;
(2019)
Drug War Pathologies: Embedded Corporatism and U.S. Drug Enforcement in the Americas
(/isis/citation/CBB525075418/)
Article
Podolsky, Scott H.;
Greene, Jeremy A.;
(2009)
Keeping Modern in Medicine: Pharmaceutical Promotion and Physician Education in Postwar America
(/isis/citation/CBB000932130/)
Book
Greene, Jeremy A.;
Watkins, Elizabeth Siegel;
(2012)
Prescribed: Writing, Filling, Using, and Abusing the Prescription in Modern America
(/isis/citation/CBB001214574/)
Book
Sara E. Black;
(2022)
Drugging France: Mind-Altering Medicine in the Long Nineteenth Century
(/isis/citation/CBB100452937/)
Book
David A. Guba Jr;
(2020)
Taming Cannabis: Drugs and Empire in Nineteenth-Century France
(/isis/citation/CBB831549564/)
Article
Kessel, Nils;
(2013)
“Doriden von Ciba: Sleeping Pills, Pharmaceutical Marketing, and Thalidomide, 1955--1963
(/isis/citation/CBB001320754/)
Article
Patricia Barton;
(2020)
“Who Takes the Blame?”: Retail Chemists, Doctors, and the Control of “Dangerous Drugs” in Inter-War Britain
(/isis/citation/CBB783230220/)
Article
Gabriel, Joseph M.;
(2011)
Restricting the Sale of “Deadly Poisons”: Pharmacists, Drug Regulation, and Narratives of Suffering in the Gilded Age
(/isis/citation/CBB001220743/)
Article
Abraham, John;
Davis, Courtney;
(2010)
Discovery and Management of Adverse Drug Reactions: The Nomifensine Hypersensitivity Syndrome, 1977--1986
(/isis/citation/CBB000932837/)
Article
Enrico Cevolani;
(2016)
Un futuro per la canapa? Dall'alimentazione all'industria, il potenziale trascurato di una pianta straordinaria
(/isis/citation/CBB591727814/)
Book
Fisher, Jill;
(2009)
Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials
(/isis/citation/CBB000953570/)
Article
Gerald, Michael C.;
(2006)
Drugs and Alcohol Go to Hollywood
(/isis/citation/CBB001020735/)
Book
Dumit, Joseph;
(2012)
Drugs for Life: How Pharmaceutical Companies Define Our Health
(/isis/citation/CBB001450628/)
Article
Schondelmeyer, Stephen W.;
(2009)
Recent Economic Trends in American Pharmacy
(/isis/citation/CBB000933448/)
Be the first to comment!